No Data
Adverum Biotechnologies' Promising AMD Treatment Advances
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Adverum Biotechnologies Inc (NASDAQ:ADVM) released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD).The 26-week interim analysis was
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
Adverum Biotechnologies Shares Rise As Eye Disease Treatment Study Advances
By Michael Susin Adverum Biotechnologies shares were higher early Wednesday after the company said that its therapy for wet age-related macular degeneration was selected for a late-stage study.
Adverum Reports Positive Interim Results in Study of Investigational Wet AMD Drug
Adverum Biotechnologies (ADVM) said Wednesday that a 26-week interim analysis of its mid-stage trial of its novel gene therapy candidate, Ixo-vec, in patients with wet age-related macular
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.Bloom Energy said it entered into a